HOME >> BIOLOGY >> NEWS
Gene predicts better outcome as cortex normalizes in teens with ADHD

Brain areas that control attention were thinnest in children with attention deficit hyperactivity disorder (ADHD) who carried a particular version of a gene in a study by the National Institutes of Healths (NIH) National Institute of Mental Health (NIMH). However, the areas, on the right side of the brains outer mantle, or cortex, normalized in thickness during the teen years in these children, coinciding with clinical improvement. Although this particular gene version increased risk for ADHD, it also predicted better clinical outcomes and higher IQ than two other common versions of the same gene in youth with ADHD.

Since this gene version had similar structural effects in healthy children as in children with the disorder, our findings suggest that ADHD is at the far end of a continuum of normal traits, said Philip Shaw, M.D., NIMH Child Psychiatry Branch, who led the research. ADHD likely stems from interactions between several such genes and non-genetic factors.

Shaw, Judith Rapoport M.D., and colleagues report on their magnetic resonance imaging (MRI) study in the August 2007 Archives of General Psychiatry.

This study provides us with a first glimpse of how variation in a specific gene influences both brain development and clinical prognosis in ADHD, said NIMH Director Thomas R. Insel, M.D.

When the NIMH researchers first reported last year that normalization of right cortex thickening was associated with better clinical outcomes in ADHD, there were few hints of a genetic connection. Yet evidence from several previous studies led them to suspect involvement of an ADHD-implicated version of a gene that codes for a receptor protein that binds to the brain chemical messenger dopamine.

This version of the dopamine D4 receptor gene, called the 7-repeat variant, accounts for about 30 percent of the genetic risk for ADHD, making it by far the strongest candidate gene implicated in the disorder. Its called the 7-rep
'"/>

Contact: Jules Asher
NIMHpress@nih.gov
301-443-4536
NIH/National Institute of Mental Health
6-Aug-2007


Page: 1 2 3

Related biology news :

1. Marker predicts pancreatic cancer outcome after surgery, Jefferson surgeon finds
2. Major study predicts grim future for Europes seas
3. FDG-PET imaging clearly predicts lung cancer patients response to chemotherapy
4. NASA predicts nongreen plants on other planets
5. Gene profiling predicts resistance to breast cancer drug Herceptin
6. Mathematical model predicts cholera outbreaks
7. New test predicts blood cancers sensitivity to experimental cancer drug
8. Blood test predicts cardiac events and death in heart patients
9. Ocean temperature predicts spread of marine species
10. New biomarker predicts effectiveness of breast cancer drugs
11. New research predicts US entry of H5N1 avian influenza

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/21/2020)... , ... August 19, 2020 , ... ... LLC and SalivaBio LLC, businesses dedicated to Salivary Bioscience for more than twenty ... recently published book by Springer, " Salivary Bioscience: Foundations of Interdisciplinary Saliva Research ...
(Date:8/21/2020)... ... August 20, 2020 , ... ... Hassan Movahhed , a Clinical Operations executive with expertise in clinical trial planning ... the firm as an Expert Consultant. Throughout his career, Mr. Movahhed has helped ...
(Date:8/12/2020)... ... August 12, 2020 , ... Mosio recently announced ... for public health agencies of all sizes. With a focus on tracking symptoms ... find appropriate health care, Mosio helps public health departments automate communications and provide ...
Breaking Biology News(10 mins):
(Date:8/15/2020)... ... August 13, 2020 , ... Inc. magazine today revealed ... prestigious ranking of the nation’s fastest-growing private companies. The list represents a unique ... independent small businesses. Intuit, Zappos, Under Armour, Microsoft, Patagonia, and many other well-known ...
(Date:8/12/2020)... ... August 11, 2020 , ... ... making available for free its new white paper – Simulated Transport Methodologies. ... into today’s biologics licensing application (BLA). In response, Modality Solutions shares an ...
(Date:8/7/2020)... ... 06, 2020 , ... VGXI, a highly regarded CDMO supporting ... purchase of greenfield for a new, expanded manufacturing facility. The site is located ... the initial acquisition, with an option to purchase an additional 21 acres for ...
(Date:8/3/2020)... ... ... Introducing Ardent Animal Health – MediVet Biologics rebrands company and positions its platform ... Biologics since its formation in 2016, the company is relaunching itself under the Ardent ... its base of innovative therapies for osteoarthritis and cancer. , ...
Breaking Biology Technology:
Cached News: